Displaying 1181 - 1200 of 1904
FTC Challenges Proposed Merger of Staples, Inc. and Office Depot, Inc.
Federal Trade Commission Appoints Lorrie Cranor as Chief Technologist
FTC Requires NXP Semiconductors N.V. to Divest RF Power Amplifier Assets as a Condition of Acquiring Freescale Semiconductor Ltd.
FTC Staff Advises New York State Public Service Commission On Improving Proposal to Transform Electric Distribution System
FTC Amicus Brief Urges Appeals Court to Reverse District Court Ruling that Incorrectly Insulates Pharmaceutical Manufacturers from Antitrust Scrutiny
FTC Approves Final Order Preserving Competition in the U.S. Markets for Generic Drugs to Treat Certain Types of Ulcers, and Thyroid Conditions
FTC Approves Final Order Preserving Competition in U.S. Markets for Two Types of Orthopedic Devices
FTC Approves Final Order Requiring National Association of Animal Breeders to Eliminate Rules that Restrict Competition among Its Members
FTC Challenges Proposed Merger of Two West Virginia Hospitals
National Association of Animal Breeders, Inc., In the Matter of
The National Association of Animal Breeders (NAAB) agreed to remove provisions in its Code of Ethics that the FTC charged limit competition among its members. The consent order settling the FTC’s allegations requires NAAB to end certain advertising restrictions, remove references to the restrictions from its website and official documents, publish and distribute an announcement regarding the consent agreement and the resulting changes to the Code of Ethics, and implement an antitrust compliance program.
FTC Amicus Brief Urges Appeals Court to Reverse Decision in Case of Alleged Discrimination in Package Sizes
FTC Requires Mylan to Sell Rights to Seven Generic Pharmaceuticals as a Condition of Acquiring Perrigo Company
FTC Staff: South Carolina Should Consider the Competitive Impact of Legislation Affecting Advanced Practice Registered Nurses
FTC Dismisses Complaint against Steris and Synergy
FTC Issues Final Orders Settling Charges of Illegal Agreement not to Compete
Steris/Synergy Health, In the Matter of
The FTC issued an administrative complaint charging that Steris Corporation’s proposed $1.9 billion acquisition of Synergy Health plc would violate the antitrust laws by significantly reducing future competition in regional markets for sterilization of products using radiation, particularly gamma or x-ray radiation. The Commission also authorized agency staff to seek a temporary restraining order and preliminary injunction in federal court to maintain the status quo pending an administrative trial on the merits. According to the FTC, it is unlikely that new competitors in the market for contract radiation sterilization services would replicate the competition that would be eliminated by the merger. The Commission alleged that the challenged acquisition would eliminate likely future competition between Steris’s gamma sterilization facilities and Synergy’s planned x-ray sterilization facilities in the United States, thus depriving customers of an alternative sterilization service and additional competition. On September 25, 2015 the district court denied the FTC motion for a PI. On October 30, the Commission dismissed the administrative complaint.
Marketer of Rug Accessory Settles FTC Charges of Invitation to Collude with Competitor
FTC Staff Provides Comments to Pennsylvania General Assembly on Proposals Affecting Pre-Need Cemetery Sales
Displaying 1181 - 1200 of 1904